MELA Sciences Predictive Probability Study Supports Increased Diagnostic Accuracy by Dermatologists for Melanoma

[Marketwired] – MELA Sciences, Inc. , developer of the MelaFind® system, an optical diagnostic device approved for use in the U.S. and the European Union to assist dermatologists in melanoma diagnosis, today announced … more

View todays social media effects on MELA

View the latest stocks trending across Twitter. Click to view dashboard

See who MELA is hiring next, click here to view